on VALBIOTIS (EPA:ALVAL)
Valbiotis Liquidity Contract Half-Yearly Report
On January 19, 2026, Valbiotis, a French laboratory specializing in food supplements, published the half-year report on its liquidity contract. Managed by Portzamparc – Groupe BNP Paribas, this contract aimed to regulate the market for its shares. As of December 31, 2025, Valbiotis held 40,894 shares and €24,765.63 in its liquidity account, down from 41,924 shares and €21,433.93 on June 30, 2025.
During the second half of 2025, 132,602 shares were purchased for €99,305.03, while 133,632 shares were sold for a total of €102,719.23. The total number of transactions reached 680, demonstrating sustained market activity.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news